Business
BioSpectrum Asia
World Bank supports Bosnia and Herzegovina in strengthening healthcare
The World Bank’s Board of Executive Directors has approved a $75 million Second Health Sectors Programmatic Development Policy Loan for Bosnia and Herzegovina (BiH).
1 min |
March 2025
BioSpectrum Asia
GHIT announces $12.7 M worth investment for developing diagnostics and drugs for malaria, NTDs
The Global Health Innovative Technology (GHIT) Fund, headquartered in Japan, has announced a total investment of approximately JPY 2 billion ($12.7 million) in eight projects for the development of new diagnostics and drugs for neglected tropical diseases (NTDs) and malaria.
1 min |
March 2025
BioSpectrum Asia
NIH to lead implementation of National Plan to End Parkinson's Act in US
With support from the US Department of Health and Human Services (HHS) Office of the Assistant Secretary for Health (OASH), the National Institutes of Health (NIH) is leading the implementation of the Dr. Emmanuel Bilirakis and Jennifer Wexton National Plan to End Parkinson’s Act, which was signed into law on July 2, 2024.
1 min |
March 2025
BioSpectrum Asia
Sequential & AMILI secure $1.8M UK-Singapore R&D project
Sequential Skin, a world leader in skin microbiome testing, and AMILI, a leading expert in gut microbiome science, have been awarded the prestigious UK-Singapore Collaborative R&D Grant.
1 min |
March 2025
BioSpectrum Asia
Thermo Fisher introduces Invitrogen EVOS S1000 Spatial Imaging System
Thermo Fisher Scientific Inc., the world leader in serving science, has introduced the Invitrogen EVOS S1000 Spatial Imaging System.
1 min |
March 2025
BioSpectrum Asia
UPES announces strategic partnership with Medical University of the Americas
The School of Health Sciences and Technology (SOHST) at UPES, a multi-disciplinary university in India, has announced a strategic first-of-itskind partnership with the Medical University of the Americas (MUA).
1 min |
March 2025
BioSpectrum Asia
Paris pushing mRNA vaccine development timelines to new speeds
Scientists in Paris are set to advance new technology that could streamline the production of mRNA-based vaccines while also improving global access to the technology.
1 min |
March 2025
BioSpectrum Asia
Korea offers breakthrough in Alzheimer's treatment
A 3D model accurately mimicking the Blood-Brain Barrier (BBB) in a laboratory environment has been successfully developed by research teams led by Professor Jinah Jang from the Departments of Mechanical Engineering, Life Sciences, IT Convergence Engineering, and the Graduate School of Convergence at Pohang University of Science and Technology (POSTECH), and Professor Sun Ha Paek from the Department of Neurosurgery at Seoul National University Hospital, in South Korea.
1 min |
March 2025
BioSpectrum Asia
Dr. Reddy's Lab inks oncology deal of $131 M with Shanghai Henlius Biotech
Dr. Reddy’s Laboratories SA, wholly-owned subsidiary of India-based Dr. Reddy’s Laboratories Ltd has entered into a license agreement with Shanghai Henlius Biotech, Inc. related to the development and commercialisation of HLX15, Henlius’s investigational daratumumab biosimilar candidate to Darzalex & Darzalex Faspro.
1 min |
March 2025
BioSpectrum Asia
India develops drug delivery system to revolutionise treatment of Rheumatoid Arthritis
Researchers from Institute of Nano Science and Technology (INST) Mohali, an autonomous institution of the Department of Science and Technology (DST), Government of India, have developed an innovative “self-actuating” drug delivery system that could revolutionise the treatment of rheumatoid arthritis (RA) by targeting inflammation directly within the joints so that therapeutic agents are released only when needed.
1 min |
March 2025
BioSpectrum Asia
NephroPlus increases footprint in the Philippines with acquisition of 7 dialysis centres
NephroPlus, Asia’s largest dialysis care network, has acquired seven new dialysis clinics in the Philippines, enhancing its position as a leading dialysis provider in the country.
1 min |
March 2025
BioSpectrum Asia
India and Indonesia ink MoU in the field of traditional medicine
The Prime Minister of India, Narendra Modi and the President of Indonesia, Prabowo Subianto witnessed the Exchange of Memorandum of Understanding (MoU) between India and Indonesia.
1 min |
March 2025
BioSpectrum Asia
BioAsia 2025 announces Genome Valley Excellence Award to Singapore's Prof. Patrick Tan
BioAsia, Asia's largest annual global biotechnology and life sciences forum organised by the Government of Telangana, has announced that the prestigious Genome Valley Excellence Award has been conferred upon Prof. Patrick Tan, Executive Director of PRECISE (Precision Health Research, Singapore), National University of Singapore, for his outstanding contributions to precision medicine, cancer genomics, and population health research.
1 min |
March 2025
BioSpectrum Asia
Syngene CEO Jonathan Hunt steps down, Peter Bains takes over
Syngene International Limited has announced that Jonathan Hunt has stepped down from his role as Managing Director (MD) & Chief Executive Officer (CEO) as well as from the Board of Directors to pursue other opportunities in due course.
1 min |
March 2025
BioSpectrum Asia
Daiichi Sankyo appoints Hiroyuki Okuzawa as CEO
Daiichi Sankyo Company has appointed Hiroyuki Okuzawa, 62, to succeed Sunao Manabe, DVM, PhD as Chief Executive Officer (CEO), effective April 1, 2025. Dr Manabe will transition from his current role of Representative Director, Executive Chairperson and CEO to Representative Director and Executive Chairperson while Okuzawa will transition to Representative Director, President and CEO.
1 min |
March 2025
BioSpectrum Asia
Chugai and GSK sign collaboration agreement for anti-dengue virus antibody AID351
Japan's Chugai Pharmaceutical Co. has signed a collaboration agreement with GSK's Global Health Unit (GSK GH) for the development of an anti-dengue virus antibody.
1 min |
March 2025
BioSpectrum Asia
Bain Capital to acquire Mitsubishi Tanabe Pharma for $3.3 B
Bain Capital, a leading global private investment firm, has signed a definitive agreement to acquire Mitsubishi Tanabe Pharma Corporation (MTPC) in a carve-out transaction from Mitsubishi Chemical Group Corporation.
1 min |
March 2025
BioSpectrum Asia
Julie Kim to succeed Christophe Weber as CEO of Takeda in June 2026
Japan headquartered pharmaceutical firm Takeda has announced that its Board of Directors have made the decision unanimously to appoint Julie Kim, currently president of Takeda’s US Business Unit, as the successor to Christophe Weber, Takeda’s president, chief executive officer (CEO) and representative director, when Weber retires from the company in June 2026.
1 min |
March 2025
BioSpectrum Asia
Vaxxas advances $4.8 M programme for needle-free thermostable mRNA vaccines
Vaxxas, an Australia-based clinical-stage biotechnology company commercialising a novel high-density microarray patch (HD-MAP) vaccination platform, has announced that Norwaybased Coalition for Epidemic Preparedness Innovations (CEPI) has approved the progression of a $4.8 million (AU$7.2 million) programme to develop heat-stable, dried-formulation mRNA vaccines delivered using Vaxxas’ needle-free high-density microarray patch (HD-MAP).
1 min |
March 2025
BioSpectrum Asia
PHC partners with CCRM in Canada to develop primary T-cell expansion culture processes
Japan-based PHC Corporation has signed a Master Collaboration Agreement with CCRM (based in Canada) to work together on the development of primary T-cell expansion culture processes that will seek to accelerate the manufacturing of cell and gene therapy (CGT) products.
1 min |
March 2025
BioSpectrum Asia
Korea announces Top 10 Promising Biotechnologies of 2025
The Ministry of Science and ICT and the Korea Research Institute of Bioscience and Biotechnology have announced the \"Top 10 Promising Biotechnologies of 2025\", presenting a vision for the future of life sciences.
1 min |
March 2025
BioSpectrum Asia
Singapore to establish Communicable Diseases Agency
The Ministry of Health (MOH) in Singapore will establish a new Statutory Board, the Communicable Diseases Agency (CDA), on April 1, 2025.
1 min |
March 2025
BioSpectrum Asia
Hong Kong develops world's smallest multifunctional biomedical robot
Researchers from the School of Engineering of the Hong Kong University of Science and Technology have successfully developed the world's smallest multifunctional biomedical robot, which is 60 per cent smaller than current models.
1 min |
March 2025
BioSpectrum Asia
American University in Dubai partners with University of Pennsylvania to establish new School of Medicine
The American University in Dubai (AUD) has completed a Memorandum of Understanding (MoU) to partner with the University of Pennsylvania’s Perelman School of Medicine (Penn Medicine) in establishing the AUD School of Medicine in Dubai.
1 min |
March 2025
BioSpectrum Asia
AdvanCell partners with Lilly to develop new targeted alpha therapies for cancer treatment in Australia
AdvanCell, a radiopharmaceutical company, has announced the expansion of the scope and scale of its strategic collaboration with Eli Lilly and Company for the research and development of innovative treatments for various cancers.
1 min |
March 2025
BioSpectrum Asia
Australia offers new treatment hope for childhood cancers
University of Queensland (UQ) research using \"natural killer\" cells may lead to the first new treatment for a devastating childhood cancer in 40 years.
1 min |
March 2025
BioSpectrum Asia
XDENT LAB expands largest removable denture factory in Vietnam
XDENT LAB, one of the leading providers in the field of Removable Denture manufacturing in Vietnam, has officially announced the expansion of its production facility, making it the largest in the country.
1 min |
March 2025
BioSpectrum Asia
UK launches world-leading AI trial to tackle breast cancer
The Department of Health and Social Care in the UK government has announced that nearly 700,000 women across the country will take part in a world-leading trial to test how cutting-edge artificial intelligence (AI) tools can be used to catch breast cancer cases earlier.
1 min |
March 2025
BioSpectrum Asia
WHO certifies Georgia malaria-free
Following a nearly century-long effort, Georgia has been certified malaria-free by the World Health Organization (WHO) on January 23.
1 min |
March 2025
BioSpectrum Asia
New Zealand announces Public Health Surveillance Strategy
New Zealand’s first Public Health Surveillance Strategy has been announced by the Ministry of Health (MoH) on how to gather and coordinate public health information to better protect New Zealanders against threats to their health and wellbeing.
1 min |